Onchocerciasis is not a major cause of blindness in two endemic villages in Sierra Leone
- PMID: 39825399
- PMCID: PMC11748601
- DOI: 10.1186/s13104-024-07051-9
Onchocerciasis is not a major cause of blindness in two endemic villages in Sierra Leone
Abstract
Objective: Sierra Leone, a country where onchocerciasis is endemic in 14 of the 16 districts, was the focus of our investigation. Despite 17 rounds of annual ivermectin treatment since 2005, a report circulated by a local politician indicated an increase in cases of suspected onchocerciasis-related vision impairment in two villages (Mangobo and Petifu) in Tonkolili district. In response, the National Neglected Tropical Disease Program conducted a comprehensive investigation. Ophthalmological, parasitological, and serological tests were conducted using standard procedures to determine the relationship between self-reported vision loss and onchocerciasis in adults. In addition, serological tests were carried out on children aged 5 to 9 years to assess the recent status of exposure to onchocerciasis in the two villages.
Results: Reported vision loss in 37 patients was mainly due to cataracts (35.1%), allergic conjunctivitis (18.9%), refractive error (10.8%), and other conditions not related to onchocerciasis. There were 40.7% of all adults (N = 54) tested and 29.0% of 31 persons with self-reported vision loss who were positive for Ov-16 IgG4 antibodies, suggesting a history of exposure to onchocerciasis. However, otoscopic eye examinations and microscopic skin snip tests were all negative for Onchocerca volvulus microfilariae, indicating no active or low-intensity infection among adults and a low or zero risk of serious ocular morbidity in the two villages. Onchocerciasis may no longer be a major cause of blindness in these two villages. Apparently, 4.6% of 153 children aged 5 to 9 years tested positive for Ov-16 IgG4 antibodies, suggesting that onchocerciasis transmission is likely still ongoing in the two villages. The data presented here suggest that more annual rounds of mass treatment with ivermectin with high coverage are needed to eliminate onchocerciasis transmission in this area.
Keywords: Onchocerciasis; Ov-16 IgG4 antibodies; Sierra Leone; Skin snip; Vision loss.
© 2024. The Author(s).
Conflict of interest statement
Declarations. Ethical approval: The onchocerciasis elimination was part of the national neglected tropical disease elimination program, and this investigation was in response to community requests and conducted by the NNTDP of the Ministry of Health Sierra Leone. Prior to the surveys, permission was received from the traditional authorities and the Paramount Chief of the chiefdom. A community meeting was held, and oral informed consent/assent was obtained from village chiefs and adult participants themselves before they were examined, and samples collected. For children, permission was given from parents/guardians on behalf of each child before DBS samples were collected. All participants were eligible for inclusion without discrimination on gender, social status, religion, or ethnicity. Participation was entirely voluntary, and they could participate and/or withdraw at any time. The data were securely stored in the NTDP database and no identity of participants can be revealed upon publication of this paper. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Figures



Similar articles
-
Impact of five annual rounds of mass drug administration with ivermectin on onchocerciasis in Sierra Leone.Infect Dis Poverty. 2018 Apr 6;7(1):30. doi: 10.1186/s40249-018-0410-y. Infect Dis Poverty. 2018. PMID: 29628019 Free PMC article.
-
Impact assessment of onchocerciasis through lymphatic filariasis transmission assessment surveys using Ov-16 rapid diagnostic tests in Sierra Leone.Parasit Vectors. 2024 Mar 11;17(1):121. doi: 10.1186/s13071-024-06198-5. Parasit Vectors. 2024. PMID: 38468307 Free PMC article.
-
Ocular onchocerciasis and the intensity of infection in the community. IV. The degraded forest of Sierra Leone.Trop Med Parasitol. 1992 Jun;43(2):75-9. Trop Med Parasitol. 1992. PMID: 1519029
-
Onchocerca volvulus infection and serological prevalence, ocular onchocerciasis and parasite transmission in northern and central Togo after decades of Simulium damnosum s.l. vector control and mass drug administration of ivermectin.PLoS Negl Trop Dis. 2018 Mar 1;12(3):e0006312. doi: 10.1371/journal.pntd.0006312. eCollection 2018 Mar. PLoS Negl Trop Dis. 2018. PMID: 29494606 Free PMC article.
-
Onchocerciasis and other eye problems in developing countries: a challenge for optometrists.J Am Optom Assoc. 1993 Oct;64(10):699-702. J Am Optom Assoc. 1993. PMID: 8245390 Review.
References
-
- WHO. Ending the neglect to attain the Sustainable Development Goals – A road map for neglected tropical diseases 2021–2030. Geneva: World Health Organization; 2020.
-
- Kargbo-Labour I, Bah MS, Vinkeles Melchers NVS, Conteh A, Redwood-Sawerr V, Stolk WA, Paye J, Sonnie M, Veinoglou A, Koroma JB, et al. Impact assessment of onchocerciasis through lymphatic filariasis transmission assessment surveys using Ov–16 rapid diagnostic tests in Sierra Leone. Parasit Vectors. 2024;17:121. - PMC - PubMed
-
- WHO. Onchocerciasis Control in Sierra Leone: achievements and prospects after OCP. World Health Organization; 2002.
-
- Yameogo L. Special intervention zones. Ann Trop Med Parasitol. 2008;102(Suppl 1):23–4. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources